Phase I metabolism of the recently emerged synthetic cannabinoid CUMYL-PEGACLONE and detection in human urine samples-Reference-Cited by-同舟云学术

Phase I metabolism of the recently emerged synthetic cannabinoid CUMYL-PEGACLONE and detection in human urine samples

Author:

Mogler Lukas¹²^ORCID,Wilde Maurice¹²,Huppertz Laura M.¹,Weinfurtner Georg³,Franz Florian¹²^ORCID,Auwärter Volker¹^ORCID

Affiliation:

1. Institute of Forensic Medicine, Forensic Toxicology, Medical Center - University of Freiburg, Faculty of Medicine; University of Freiburg; Germany

2. Hermann Staudinger Graduate School; University of Freiburg; Germany

3. Clinical Chemistry Laboratory, medbo®; District Hospital for Mental Health; Regensburg Germany

Funder

Prevention of and Fight against Crime program of the European Commission

Deutsche Forschungsgemeinschaft

Publisher

Wiley

Subject

Spectroscopy,Pharmaceutical Science,Environmental Chemistry,Analytical Chemistry

Reference15 articles.

1. Structural characterization and pharmacological evaluation of the new synthetic cannabinoid CUMYL-PEGACLONE;Angerer;Drug Test Anal,2017

2. Detection of the recently emerged synthetic cannabinoid 5F-MDMB-PICA in 'legal high' products and human urine samples;Mogler;Drug Test Anal,2017

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

4. Cannabinoids;Forensic Toxicology;2022